Skip to main content

Phoenix S&T Nets $500K from Southeast Pennsylvania Greenhouse

NEW YORK (GenomeWeb News) – Biomolecular analysis and proteomics company Phoenix S&T has received a $500,000 investment from BioAdvance, the Biotechnology Greenhouse of Southeastern Pennsylvania.
 
BioAdvance said today that it has provided the Chester, Pa.-based company with the funding as one of three firms it has newly invested in with a total of $1.5 million.
 
PST has patented injection molded nanospray devices used in biomolecular analysis for proteomics and clinical diagnostics applications.
 
BioAdvance derives funding from the $20 million Greenhouse Fund that was established in 2002. It provides initial seed funds of up to $500,000, and it provides business assistance and other resources.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.